Clinical trial
hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1…
NCT00285194 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00285194 |
|---|---|
| Title | hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients |
| Official title | hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | Juvenile Diabetes Research Foundation |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes, Hypoglycemia |
| Intervention type | Drug |
| Interventions | Allogeneic Islets of Langerhans, hOKT3γ1 (Ala-Ala) |
| Enrollment | 6 |
| Start date | Apr 1, 2000 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Feb 1, 2006 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: